BackgroundCheck.run
Search For

Craig B Wilde, 62492 Via Sorrento, Morgan Hill, CA 95037

Known as:
Craig Brian Wilde Craig Wild
Related to:
Ben Wild Tyler Wilde

Craig Wilde Phones & Addresses

492 Via Sorrento, Morgan Hill, CA 95037    408-6599462   

4227 Whispering Pines Dr, Santa Maria, CA 93455    805-9341021   

1402 Trimera Ave, Santa Maria, CA 93458   

Covina, CA   

17960 Mirasol Way, San Diego, CA 92128    858-5218757   

Lancaster, CA   

Lompoc, CA   

Azusa, CA   

17740 Mclaughlin Ct, Morgan Hill, CA 95037   

Work

Company: Los angeles county office of education - Los Angeles, CA 2010 Position: Administrative services officer

Education

School / High School: Azusa Pacific University- Azusa, CA 1992 Specialities: M.B.A. in Business Administration
Get Report
Control this profile

Mentions for Craig B Wilde

Craig Wilde resumes & CV records

Resumes

Craig Wilde Photo 33

Craig Wilde

Skills:
Home Repair and Explosives
Craig Wilde Photo 34

Craig Wilde

Craig Wilde Photo 35

Craig Wilde

Work:
LOS ANGELES COUNTY OFFICE OF EDUCATION - Los Angeles, CA 2010 to 2011
Administrative Services Officer SAN DIEGO MIRAMAR COLLEGE - San Diego, CA 2008 to 2009
Vice President of Administrative Services ANTELOPE VALLEY COLLEGE - Lancaster, CA 2007 to 2008
Director, Business Services SANTA YNEZ BAND OF CHUMASH INDIANS - Santa Ynez, CA 2004 to 2006
Finance Officer ALLAN HANCOCK COMMUNITY COLLEGE DISTRICT - Santa Maria, CA 1998 to 2004
Director, Business Services CITRUS COMMUNITY COLLEGE DISTRICT - Glendora, CA 1988 to 1998
Director of Purchasing, Warehouse
Education:
Azusa Pacific University - Azusa, CA 1992
M.B.A. in Business Administration Western Association of College and University Business Officers University of California - Santa Barbara, CA 1990
Certificate Southern Utah State College - Cedar City, UT 1984
B.S. in Business Administration Marketing Allan Hancock College - Santa Maria, CA 1982
A.A. in Business

Publications & IP owners

Us Patents

Chemokine Panec-1 Polynucleotides And Compositions And Methods Related Thereto

US Patent:
7005509, Feb 28, 2006
Filed:
Feb 17, 1995
Appl. No.:
08/390740
Inventors:
Roger Coleman - Mountain View CA, US
Olga Bandman - Mountain View CA, US
Craig G. Wilde - Sunnyvale CA, US
Assignee:
Incyte Corporation - Wilmington DE
International Classification:
C07H 21/00
C12Q 1/68
C12P 19/34
US Classification:
536 231, 536 221, 435 6, 435 912
Abstract:
The present invention provides nucleotide and amino acid sequences that identify and encode novel expressed chemokines (PANEC-1 and PANEC-2) from human pancreas cells. The present invention also provides for antisense molecules to the nucleotide sequences which encode PANEC-1 and PANEC-2, expression vectors for the production of purified PANEC-1 and PANEC-2, antibodies capable of binding specifically to PANEC-1 and PANEC-2, hybridization probes or oligonucleotides for the detection of PANEC-1- or PANEC-2-encoding nucleotide sequences, genetically engineered host cells for the expression of PANEC-1 and PANEC-2, diagnostic tests for chemokine activation based on PANEC-1- and PANEC-2-encoding nucleic acid molecules and antibodies capable of binding specifically to the protein.

Chemokine Expressed In Fetal Spleen, Its Production And Uses

US Patent:
2002014, Oct 3, 2002
Filed:
May 29, 2002
Appl. No.:
10/158366
Inventors:
Roger Coleman - Mountain View CA, US
Craig Wilde - Sunnyvale CA, US
Jeffrey Seilhamer - Los Altos Hills CA, US
Assignee:
Incyte Genomics, Inc.
International Classification:
C07K014/52
A01K067/00
C07H021/04
C12P021/02
C12N005/08
C12N001/21
US Classification:
435/069500, 435/320100, 435/366000, 530/351000, 435/252300, 536/023500, 800/008000
Abstract:
The present invention provides nucleotide and amino acid sequences that identify and encode a novel expressed chemokine (FSEC) from human fetal spleen cells. The present invention also provides for antisense molecules to the nucleotide sequences which encode FSEC, expression vectors for the production of purified FSEC, antibodies capable of binding specifically to FSEC, hybridization probes or oligonucleotides for the detection of FSEC-encoding nucleotide sequences, genetically engineered host cells for the expression of FSEC, diagnostic tests for chemokine activation based on FSEC-encoding nucleic acid molecules and antibodies capable of binding specifically to the protein.

Chemokines Expressed In Pancreas

US Patent:
2002015, Oct 24, 2002
Filed:
Jan 25, 2002
Appl. No.:
10/057275
Inventors:
Roger Coleman - Mountain View CA, US
Olga Bandman - Mountain View CA, US
Craig Wilde - Sunnyvale CA, US
Assignee:
Incyte Pharmaceuticals, Inc.
International Classification:
C07K014/52
A01K067/00
C07H021/04
C12P021/02
C12N001/21
C12N005/06
US Classification:
435/069500, 435/320100, 435/325000, 435/252300, 800/008000, 530/351000, 536/023500
Abstract:
The present invention provides nucleotide and amino acid sequences that identify and encode novel expressed chemokines (PANEC-1 and PANEC-2) from human pancreas cells. The present invention also provides for antisense molecules to the nucleotide sequences which encode PANEC-1 and PANEC-2, expression vectors for the production of purified PANEC-1 and PANEC-2, antibodies capable of binding specifically to PANEC-1 and PANEC-2, hybridization probes or oligonucleotides for the detection of PANEC-1- or PANEC-2- encoding nucleotide sequences, genetically engineered host cells for the expression of PANEC-1 and PANEC-2, diagnostic tests for chemokine activation based on PANEC-1- and PANEC-2- encoding nucleic acid molecules and antibodies capable of binding specifically to the protein.

Dna Encoding Liver Expressed Chemokine

US Patent:
2003008, May 1, 2003
Filed:
Nov 12, 2002
Appl. No.:
10/293705
Inventors:
Craig Wilde - Sunnyvale CA, US
Phillip Hawkins - Mountain View CA, US
Olga Bandman - Mountain View CA, US
Jeffrey Seilhamer - Los Altos Hills CA, US
Assignee:
Incyte Genomics, Inc. - Palo Alto CA
International Classification:
C07K014/52
A01K067/00
C07H021/04
C12P021/02
C12N005/06
A61K038/19
C12N001/21
US Classification:
530/351000, 536/023500, 424/085100, 435/069500, 435/320100, 435/325000, 435/252300, 800/008000
Abstract:
The present invention provides nucleotide and amino acid sequences that identify and encode novel expressed chemokines (ECs) from liver and pituitary gland tissues. The present invention also provides for antisense molecules to the nucleotide sequences which encode ECs, expression vectors for the production of purified ECs, antibodies capable of binding specifically to ECs, hybridization probes or oligonucleotides for the detection of EC-encoding nucleotide sequences, genetically engineered host cells for the expression of ECs, diagnostic tests for inflammation or disease based on EC-encoding nucleic acid molecules or antibodies capable of binding specifically to ECs, pharmaceutical compositions to treat inflammation or disease based on EC-encoding nucleic acid molecules or antibodies capable of binding specifically to ECs.

Human Map Kinase Homolog

US Patent:
5846778, Dec 8, 1998
Filed:
Aug 28, 1997
Appl. No.:
8/920296
Inventors:
Phillip R. Hawkins - Mountain View CA
Janice Au-Young - Berkeley CA
Karl J. Guegler - Menlo park CA
Craig G. Wilde - Sunnyvale CA
Assignee:
Incyte Pharmaceuticals, Inc. - Palo Alto CA
International Classification:
C12N 1500
C07K 14435
C07H 2104
US Classification:
435 691
Abstract:
The present invention provides nucleic acid and amino acid sequences that identify and encode a novel human map kinase homolog (SMAP) expressed in cells of the human stomach. The present invention also provides for PCR oligomers or hybridization probes for the detection of nucleotide sequences encoding SMAP or SMAP-like molecules, antisense molecules to the nucleotide sequences which encode SMAP, diagnostic tests based on SMAP encoding nucleic acid molecules, genetically engineered expression vectors and host cells for the production of purified SMAP, antibodies capable of binding specifically to SMAP, and agonists and inhibitors with specific binding activity for the polypeptide SMAP.

Dna Encoding A Hyaluronan Receptor Expressed In Human Umbilical Vein Endothelial Cells

US Patent:
5587301, Dec 24, 1996
Filed:
Mar 10, 1995
Appl. No.:
8/402217
Inventors:
Phillip R. Hawkins - Mountain View CA
Craig G. Wilde - Sunnyvale CA
Jeffrey J. Seilhamer - Los Altos Hills CA
Assignee:
Incyte Pharmaceuticals, Inc. - Palo Alto CA
International Classification:
C12N 510
C12N 1512
US Classification:
435 691
Abstract:
The present invention provides nucleotide and amino acid sequences that identify and encode the hyaluronan receptor (hr) from human umbilical vein endothelial cells. The present invention also provides for antisense molecules to the nucleotide sequences which encode hr, expression vectors for the production of purified HR, antibodies capable of binding specifically to HR, hybridization probes or oligonucleotides for the detecting the upregulation of HR encoding nucleotide sequences, genetically engineered host cells for the expression of HR, diagnostic tests for activated, angiogenic, inflamed or metastatic cells and/or tissues based on HR-encoding nucleic acid molecules and antibodies capable of binding specifically to the receptor.

Hyaluronan Receptor Expressed In Human Umbilical Vein Endothelial

US Patent:
5783669, Jul 21, 1998
Filed:
Aug 20, 1996
Appl. No.:
8/700178
Inventors:
Phillip R. Hawkins - Mountain View CA
Craig G. Wilde - Sunnyvale CA
Jeffrey J. Seilhamer - Los Altos Hills CA
Assignee:
Incyte Pharmaceuticals, Inc. - Palo Alto CA
International Classification:
C07K 14705
US Classification:
530350
Abstract:
The present invention provides nucleotide and amino acid sequences that identify and encode the hyaluronan receptor (hr) from human umbilical vein endothelial cells. The present invention also provides for antisense molecules to the nucleotide sequences which encode hr, expression vectors for the production of purified HR, antibodies capable of binding specifically to HR, hybridization probes or oligonucleotides for detecting the upregulation of HR encoding nucleotide sequences, genetically engineered host cells for the expression of HR, diagnostic tests for activated, angiogenic, inflamed or metastatic cells and/or tissues based on HR-encoding nucleic acid molecules and antibodies capable of binding specifically to the receptor.

Method For Detecting The Presence Of A Polynucleotide Encoding A Hyaluronan Receptor Expressed In Human Umbilical Vein Endothelial Cells

US Patent:
6025138, Feb 15, 2000
Filed:
Dec 22, 1997
Appl. No.:
8/995654
Inventors:
Phillip R. Hawkins - Mountain View CA
Craig G. Wilde - Sunnyvale CA
Jeffrey J. Seilhamer - Los Altos Hills CA
Assignee:
Incyte Pharmaceuticals, Inc. - Palo Alto CA
International Classification:
C12Q 168
C12N 1512
US Classification:
435 6
Abstract:
The present invention provides nucleotide and amino acid sequences that identify and encode the hyaluronan receptor (hr) from human umbilical vein endothelial cells. The present invention also provides for antisense molecules to the nucleotide sequences which encode hr, expression vectors for the production of purified HR, antibodies capable of binding specifically to HR, hybridization probes or oligonucleotides for detecting the upregulation of HR encoding nucleotide sequences, genetically engineered host cells for the expression of HR, diagnostic tests for activated, angiogenic, inflamed or metastatic cells and/or tissues based on HR-encoding nucleic acid molecules and antibodies capable of binding specifically to the receptor.

Possible Relatives

David A Wilde  Dean R Wilde  Deann B Wilde  Deborah S Wilde  Daniel J Wilde  Denise J Wilde  Danielle K Wilde  Craig L Johnson  Craig Stamps  Craig T Standen 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.